Document is current
Any future updates will be listed below
-
Authors
Holas, Vanessa
Thöne, Ann-Kathrin
Dose, Christina
Gebauer, Stephanie
Hautmann, Christopher
Görtz-Dorten, Anja
Kohl, Lea Teresa
Plück, Julia
Treier, Anne-Katrin
Banaschewski, Tobias
Ravens-Sieberer, Ulrike
Rößner, Veit
Hanisch, Charlotte
Kölch, Michael
Holtmann, Martin
Becker, Katja
Renner, Tobias
Geissler, Julia
Wenning, Jasmin
Huss, Michael
Poustka, Luise
Döpfner, Manfred
,
Aggensteiner, Pascal-Maurice
Bernheim, Dorothee
Beste, Christian
Bienioschek, Stefanie
Boecker, Maren
Brandeis, Daniel
Butz, Kristina
Daunke, Andrea
Fegert, Jörg M.
Ginsberg, Claudia
Giller, Franziska
Goldbeck, Carolina
Hellmich, Martin
Igel, Christine
Junghänel, Michaela
Kaman, Anne
Ritschel, Anne
Roessner, Veit
Schroth, Jennifer
Schüller, Anne
Steiner, Marion
Uhlmann, Anne
Brandeis, Daniel
Christmann, Nina
Dürrwächter, Ute
Flick, Lena
Gehring, Brigitta
Grau, Nicole
Groh, Monja
Haberhausen, Wiebke
Hebebrand, Johannes
Hiery, Alisa
Hohmann, Sarah
Igel, Christine
Jans, Thomas
Jansone, Karina
John, Katja
Kaiser, Anna
Kasperzack, Daria
Kellner, Julia
Ketter, Johanna
Kieninger, Franziska
Kirschbaum-Lesch, Inken
Krugmann, Katrin
Legenbauer, Tanja
Mann, Christopher
Martin, Franziska
Millenet, Sabrina
Mingebach, Tanja
Mross, Melinda
Pascher, Anja
Poustka, Louisa
Romanos, Marcel
Schneider, Priska
Schöllhorn, Anja
Schrott, Bastian
Schulze-Husmann, Karen
Stehr, Thomas
Steinacker, Ida
Steiner, Marie-Therese
Thöne, Ann-Katrin
Vandersleben, Henrik Uebel-von
Vetter, Paula
Weber, Linda
Wermter, Anne-Kathrin
Winkler, Matthias
Wirth, Elena
Ziegler, Mirjam
- License Information
-
More Information
Article History
Received: 15 July 2024
Accepted: 6 December 2024
First Online: 16 December 2024
Declarations
:
: MD received consulting income and research support from Lilly, Medice, Shire, Takeda, eyelevel GmbH, and Vifor and research support from the German Research Foundation, German Ministry of Education and Research, German Ministry of Health, and Innovation Fund. He received income as head, supervisor, and lecturer of the School of Child and Adolescent Cognitive Behaviour Therapy at the University Hospital Cologne and as a consultant for Child Behaviour Therapy at the National Association of Statutory Health Insurance Physicians (Kassenärztliche Bundesvereinigung). He and AGD received royalties from treatment manuals, books and psychological tests published by Beltz, Elsevier, Enke, Guilford, Hogrefe, Huber, Kohlhammer, Schattauer, Springer, and Wiley. CD received royalties for self-help books for parents and teachers of children with ADHD published by Hogrefe. A-KTh receives royalties from Hogrefe for the publication of a diagnostic instrument (DISYPS-ILF). JP received royalties from treatment manuals and psychological tests published by Hogrefe. TB served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, and Shire. He received conference support or speaker’s fees from Lilly, Medice, Novartis, and Shire. He has been involved in clinical trials conducted by Shire and Vifor Pharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press. VR has received lecture honoraria from Infectopharm and Medice companies. He has carried out clinical trials in cooperation with Servier and Shire Pharmaceuticals/ Takeda companies. CHan receives royalties from a publishing company as the author of a treatment manual. MK receives royalties from publishing companies as an author of books. He served as PI or CI in clinical trials of Lundbeck, Pascoe, and Janssen-Cilag. He received grants from the BMBF, BMFSFJ, BZgA and Bundeswehr. He served as a scientifc advisor for Janssen. The present work is unrelated to the above grants and relationships. MHo served in an advisory role for Shire and Medice and received conference attendance support or was paid for public speaking by Medice, Shire and Neuroconn. He receives research support from the German Research Foundation and the German Ministry of Education and Research. He receives royalties as editor in chief of the German Journal for Child and Adolescent Psychiatry and for text books from Hogrefe. DB served as an unpaid scientific advisor for an EU-funded neurofeedback trial unrelated to the present work. KB receives or has received research grants from the German Research Foundation (DFG), German Federal Ministry for Education and Research (BMBF), Philipps-University Marburg, Federal Joint Committee (G-BA), German Ministry for Health, University Hospital Giessen and Marburg and Rhön Klinikum. Additionally, she receives royalties from Thieme. JG has received a research grant from the Bavarian State Ministry of Family, Labor and Social Afairs. She receives royalties from Hogrefe for the publication of an ADHD treatment manual. MHu served as a member of the advisory boards of Eli Lilly and Co., Engelhardt Arzneimittel, Janssen-Cilag, Medice, Novartis, Shire, and Steiner Arzneimittel within the past 5 years; served as a consultant to Engelhardt Arzneimittel, Medice, and Steiner Arzneimittel; received honoraria from Eli Lilly and Co., Engelhardt Arzneimittel, Janssen-Cilag, Medice, Novartis, and Shire; and received unrestricted grants for investigator- initiated trials from Eli Lilly and Co., Medice, Engelhardt Arzneimittel, and Steiner Arzneimittel. LP served in an advisory or consultancy role for Shire, Roche and Infectopharm; and received speaker’s fees from Shire and royalties from Hogrefe, Kohlhammer, and Schattauer. The present work is unrelated to the above grants and relationships. All other authors declare no conflict of interest.
: Ethical approval was obtained for all participating studies. Verbal and written informed consent were obtained from all individual participants (children and caregivers) by the study centers.
